{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:23:02Z","timestamp":1770888182616,"version":"3.50.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,4]]},"DOI":"10.7759\/cureus.61658","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T15:15:39Z","timestamp":1717514139000},"source":"Crossref","is-referenced-by-count":3,"title":["Clinical Performance of Implant-Supported Prostheses in the Rehabilitation of Patients Previously Treated for Medication-Related Osteonecrosis of the Jaws (MRONJ): A Systematic Review"],"prefix":"10.7759","author":[{"given":"Eduardo","family":"Anitua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Alkhraisat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asier","family":"Eguia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero SL","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg. 2022, 80:920-43. 10.1016\/j.joms.2022.02.008","journal-title":"J Oral Maxillofac Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2018.09.008","article-title":"Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment","volume":"127","author":"Nicolatou-Galitis O","year":"2019","unstructured":"Nicolatou-Galitis O, Schi\u00f8dt M, Mendes RA, et al.. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019, 127:117-35. 10.1016\/j.oooo.2018.09.008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.23191","article-title":"Review and update on drugs related to the development of osteonecrosis of the jaw","volume":"25","author":"Eguia A","year":"2020","unstructured":"Eguia A, Bag\u00e1n-Deb\u00f3n L, Cardona F. Review and update on drugs related to the development of osteonecrosis of the jaw. Med Oral Patol Oral Cir Bucal. 2020, 25:e71-83. 10.4317\/medoral.23191","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10785","article-title":"Pathophysiology of medication-related osteonecrosis of the jaw-a minireview","volume":"7","author":"Tetradis S","year":"2023","unstructured":"Tetradis S, Allen MR, Ruggiero SL. Pathophysiology of medication-related osteonecrosis of the jaw-a minireview. JBMR Plus. 2023, 7:e10785. 10.1002\/jbm4.10785","journal-title":"JBMR Plus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2017.05.003","article-title":"The effect of chronic dental inflammation on development of Stage 0 medication-related osteonecrosis of the jaw","volume":"45","author":"Topaloglu G","year":"2017","unstructured":"Topaloglu G, Koseoglu OT, Karaca C, Kosemehmetoglu K. The effect of chronic dental inflammation on development of Stage 0 medication-related osteonecrosis of the jaw. J Craniomaxillofac Surg. 2017, 45:1158-64. 10.1016\/j.jcms.2017.05.003","journal-title":"J Craniomaxillofac Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2014.04.009","article-title":"Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease","volume":"52","author":"Bedogni A","year":"2014","unstructured":"Bedogni A, Fedele S, Bedogni G, et al.. Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease. Br J Oral Maxillofac Surg. 2014, 52:603-8. 10.1016\/j.bjoms.2014.04.009","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/dj7020055","article-title":"Idiopathic exposed bone lesions of the jaw","volume":"7","author":"Lon\u010dar Brzak B","year":"2019","unstructured":"Lon\u010dar Brzak B, Vu\u010di\u0107evi\u0107 Boras V, Kotarac Kne\u017eevi\u0107 A, Su\u0161i\u0107 M, Seiwerth S, Gabri\u0107 D. Idiopathic exposed bone lesions of the jaw. Dent J (Basel). 2019, 7:10.3390\/dj7020055","journal-title":"Dent J (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5371\/hp.2023.35.3.147","article-title":"Updating osteonecrosis of the femoral head","volume":"35","author":"Ko YS","year":"2023","unstructured":"Ko YS, Ha JH, Park JW, Lee YK, Kim TY, Koo KH. Updating osteonecrosis of the femoral head. Hip Pelvis. 2023, 35:147-56. 10.5371\/hp.2023.35.3.147","journal-title":"Hip Pelvis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/dj11050109","article-title":"Medication-related osteonecrosis: why the jawbone?","volume":"11","author":"Kuehn S","year":"2023","unstructured":"Kuehn S, Scariot R, Elsalanty M. Medication-related osteonecrosis: why the jawbone?. Dent J (Basel). 2023, 11:10.3390\/dj11050109","journal-title":"Dent J (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1592367","article-title":"Bisphosphonate and medication-related osteonecrosis of the jaw: a review","volume":"20","author":"M\u00fccke T","year":"2016","unstructured":"M\u00fccke T, Krestan CR, Mitchell DA, Kirschke JS, Wutzl A. Bisphosphonate and medication-related osteonecrosis of the jaw: a review. Semin Musculoskelet Radiol. 2016, 20:305-14. 10.1055\/s-0036-1592367","journal-title":"Semin Musculoskelet Radiol"},{"key":"ref11","article-title":"Understanding bisphosphonates and osteonecrosis of the jaw: uses and risks","volume":"19","author":"Rosini S","year":"2015","unstructured":"Rosini S, Rosini S, Bertoldi I, Frediani B. Understanding bisphosphonates and osteonecrosis of the jaw: uses and risks. Eur Rev Med Pharmacol Sci. 2015, 19:3309-17.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/biom13060973","article-title":"In vitro cytotoxicity of antiresorptive and antiangiogenic compounds on oral tissues contributing to MRONJ: systematic review","volume":"13","author":"Guirguis RH","year":"2023","unstructured":"Guirguis RH, Tan LP, Hicks RM, et al.. In vitro cytotoxicity of antiresorptive and antiangiogenic compounds on oral tissues contributing to MRONJ: systematic review. Biomolecules. 2023, 13:10.3390\/biom13060973","journal-title":"Biomolecules"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.sdentj.2022.01.003","article-title":"Medication-related osteonecrosis of the jaw (MRONJ): a review of pathophysiology, risk factors, preventive measures and treatment strategies","volume":"34","author":"AlRowis R","year":"2022","unstructured":"AlRowis R, Aldawood A, AlOtaibi M, Alnasser E, AlSaif I, Aljaber A, Natto Z. Medication-related osteonecrosis of the jaw (MRONJ): a review of pathophysiology, risk factors, preventive measures and treatment strategies. Saudi Dent J. 2022, 34:202-10. 10.1016\/j.sdentj.2022.01.003","journal-title":"Saudi Dent J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cre2.698","article-title":"Incidence and risk factors for medication-related osteonecrosis after tooth extraction in cancer patients-A systematic review","volume":"9","author":"Schwech N","year":"2023","unstructured":"Schwech N, Nilsson J, Gabre P. Incidence and risk factors for medication-related osteonecrosis after tooth extraction in cancer patients-A systematic review. Clin Exp Dent Res. 2023, 9:55-65. 10.1002\/cre2.698","journal-title":"Clin Exp Dent Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/0022034514560768","article-title":"Diabetes as a risk factor for medication-related osteonecrosis of the jaw","volume":"94","author":"Peer A","year":"2015","unstructured":"Peer A, Khamaisi M. Diabetes as a risk factor for medication-related osteonecrosis of the jaw. J Dent Res. 2015, 94:252-60. 10.1177\/0022034514560768","journal-title":"J Dent Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2020.03.022","article-title":"Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ)","volume":"58","author":"Pichardo SE","year":"2020","unstructured":"Pichardo SE, van der Hee JG, Fiocco M, Appelman-Dijkstra NM, van Merkesteyn JP. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ). Br J Oral Maxillofac Surg. 2020, 58:771-6. 10.1016\/j.bjoms.2020.03.022","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201343","article-title":"Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?","volume":"13","author":"Soutome S","year":"2018","unstructured":"Soutome S, Hayashida S, Funahara M, Sakamoto Y, Kojima Y, Yanamoto S, Umeda M. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?. PLoS One. 2018, 13:e0201343. 10.1371\/journal.pone.0201343","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s40729-016-0041-7","article-title":"Dental implants in patients treated with antiresorptive medication - a systematic literature review","volume":"2","author":"Walter C","year":"2016","unstructured":"Walter C, Al-Nawas B, Wolff T, Schiegnitz E, Gr\u00f6tz KA. Dental implants in patients treated with antiresorptive medication - a systematic literature review. Int J Implant Dent. 2016, 2:9. 10.1186\/s40729-016-0041-7","journal-title":"Int J Implant Dent"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5051\/jpis.2300120006","article-title":"Pulp and periapical disease as a risk factor for osteonecrosis of the jaw: a national cohort-based study in Korea","volume":"54","author":"Baek HJ","year":"2024","unstructured":"Baek HJ, Lee H, Lee JR, et al.. Pulp and periapical disease as a risk factor for osteonecrosis of the jaw: a national cohort-based study in Korea. J Periodontal Implant Sci. 2024, 54:65-74. 10.5051\/jpis.2300120006","journal-title":"J Periodontal Implant Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-021-04175-1","article-title":"The association between the severity of periodontitis and osteonecrosis of the jaw in patients with different cancer locations: a nationwide population-based study","volume":"26","author":"Huang YF","year":"2022","unstructured":"Huang YF, Lin KC, Liu SP, et al.. The association between the severity of periodontitis and osteonecrosis of the jaw in patients with different cancer locations: a nationwide population-based study. Clin Oral Investig. 2022, 26:3843-52. 10.1007\/s00784-021-04175-1","journal-title":"Clin Oral Investig"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57050463","article-title":"Infection as an important factor in medication-related osteonecrosis of the jaw (MRONJ)","volume":"57","author":"Otto S","year":"2021","unstructured":"Otto S, Aljohani S, Fliefel R, et al.. Infection as an important factor in medication-related osteonecrosis of the jaw (MRONJ). Medicina (Kaunas). 2021, 57:10.3390\/medicina57050463","journal-title":"Medicina (Kaunas)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1556\/1886.2023.00041","article-title":"Role of Actinomyces spp. and related organisms in the development of medication-related osteonecrosis of the jaw (MRONJ): Clinical evidence based on a case series","volume":"13","author":"K\u00f6v\u00e9r Z","year":"2023","unstructured":"K\u00f6v\u00e9r Z, B\u00e1n \u00c1, Gajd\u00e1cs M, Polg\u00e1r B, Urb\u00e1n E. Role of Actinomyces spp. and related organisms in the development of medication-related osteonecrosis of the jaw (MRONJ): Clinical evidence based on a case series. Eur J Microbiol Immunol (Bp). 2023, 13:125-34. 10.1556\/1886.2023.00041","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx RE","year":"2003","unstructured":"Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003, 61:1115-7. 10.1016\/s0278-2391(03)00720-1","journal-title":"J Oral Maxillofac Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cden.2023.07.005","article-title":"Treatment of medication-related osteonecrosis of the jaw: controversies in causality and therapy","volume":"68","author":"Halpern LR","year":"2024","unstructured":"Halpern LR, Adams DR. Treatment of medication-related osteonecrosis of the jaw: controversies in causality and therapy. Dent Clin North Am. 2024, 68:67-85. 10.1016\/j.cden.2023.07.005","journal-title":"Dent Clin North Am"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-023-03034-7","article-title":"Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts","volume":"23","author":"Zhao N","year":"2023","unstructured":"Zhao N, Li QX, Wang YF, Qiao Q, Huang HY, Guo CB, Guo YX. Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts. BMC Oral Health. 2023, 23:330. 10.1186\/s12903-023-03034-7","journal-title":"BMC Oral Health"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/jispcd.JISPCD_110_22","article-title":"Contribution of antiangiogenic agents to the risk of medication-related osteonecrosis of the jaw in combination with antiresorptive agents: preliminary results in a comparative prospective report of 59 oncologic cases","volume":"12","author":"Yanni A","year":"2022","unstructured":"Yanni A, Bouland C, Monteiro R, Rodriguez A, Loeb I, Javadian R, Dequanter D. Contribution of antiangiogenic agents to the risk of medication-related osteonecrosis of the jaw in combination with antiresorptive agents: preliminary results in a comparative prospective report of 59 oncologic cases. J Int Soc Prev Community Dent. 2022, 12:564-70. 10.4103\/jispcd.JISPCD_110_22","journal-title":"J Int Soc Prev Community Dent"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg194","article-title":"Bisphosphonates: new antiangiogenic molecules in cancer treatment?","volume":"14","author":"Vincenzi B","year":"2003","unstructured":"Vincenzi B, Santini D, Rocci L, Tonini G. Bisphosphonates: new antiangiogenic molecules in cancer treatment?. Ann Oncol. 2003, 14:806-7. 10.1093\/annonc\/mdg194","journal-title":"Ann Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0551","article-title":"Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients","volume":"13","author":"Santini D","year":"2007","unstructured":"Santini D, Vincenzi B, Galluzzo S, et al.. Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients. Clin Cancer Res. 2007, 13:4482-6. 10.1158\/1078-0432.CCR-07-0551","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::aid-cncr12>3.3.co;2-c","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers MJ","year":"2000","unstructured":"Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC. Cellular and molecular mechanisms of action of bisphosphonates. Cancer. 2000, 88:2961-78. 10.1002\/1097-0142(20000615)88:12+&lt;2961::aid-cncr12&gt;3.3.co;2-c","journal-title":"Cancer"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.21001","article-title":"Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws. A review of the literature","volume":"21","author":"Gavald\u00e1 C","year":"2016","unstructured":"Gavald\u00e1 C, Bag\u00e1n JV. Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws. A review of the literature. Med Oral Patol Oral Cir Bucal. 2016, 21:e260-70. 10.4317\/medoral.21001","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.22133","article-title":"Exposed necrotic bone in 183 patients with bisphosphonate-related osteonecrosis of the jaw: associated clinical characteristics","volume":"22","author":"Bagan L","year":"2017","unstructured":"Bagan L, Jim\u00e9nez Y, Leopoldo M, Murillo-Cortes J, Bagan J. Exposed necrotic bone in 183 patients with bisphosphonate-related osteonecrosis of the jaw: associated clinical characteristics. Med Oral Patol Oral Cir Bucal. 2017, 22:e582-5. 10.4317\/medoral.22133","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.2017.1001","article-title":"Detecting the earliest radiological signs of bisphosphonate-related osteonecrosis","volume":"224","author":"Devlin H","year":"2018","unstructured":"Devlin H, Greenwall-Cohen J, Benton J, Goodwin TL, Littlewood A, Horner K. Detecting the earliest radiological signs of bisphosphonate-related osteonecrosis. Br Dent J. 2018, 224:26-31. 10.1038\/sj.bdj.2017.1001","journal-title":"Br Dent J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/dj4030029","article-title":"Imaging in patients with bisphosphonate-associated osteonecrosis of the jaws (MRONJ)","volume":"4","author":"Berg BI","year":"2016","unstructured":"Berg BI, Mueller AA, Augello M, Berg S, Jaqui\u00e9ry C. Imaging in patients with bisphosphonate-associated osteonecrosis of the jaws (MRONJ). Dent J (Basel). 2016, 4:10.3390\/dj4030029","journal-title":"Dent J (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdsr.2018.11.004","article-title":"Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (1), role of imaging in drug-related osteonecrosis of the jaw: An up-to-date review (secondary publication)","volume":"55","author":"Tsuchimochi M","year":"2019","unstructured":"Tsuchimochi M, Kurabayashi T. Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (1), role of imaging in drug-related osteonecrosis of the jaw: An up-to-date review (secondary publication). Jpn Dent Sci Rev. 2019, 55:1-4. 10.1016\/j.jdsr.2018.11.004","journal-title":"Jpn Dent Sci Rev"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12103383","article-title":"Clinical and histopathological aspects of MRONJ in cancer patients","volume":"12","author":"Ciobanu GA","year":"2023","unstructured":"Ciobanu GA, Mogoant\u0103 L, Camen A, et al.. Clinical and histopathological aspects of MRONJ in cancer patients. J Clin Med. 2023, 12:10.3390\/jcm12103383","journal-title":"J Clin Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2019.08.018","article-title":"Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases","volume":"129","author":"Yuan A","year":"2020","unstructured":"Yuan A, Munz A, Reinert S, Hoefert S. Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020, 129:133-40. 10.1016\/j.oooo.2019.08.018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2022.01.012","article-title":"Surgical therapy in patients with medication-related osteonecrosis of the jaw is associated with disease resolution and improved quality of life: a prospective cohort study","volume":"80","author":"El-Rabbany M","year":"2022","unstructured":"El-Rabbany M, Blanas N, Sutherland S, Lam DK, Shah PS, Azarpazhooh A. Surgical therapy in patients with medication-related osteonecrosis of the jaw is associated with disease resolution and improved quality of life: a prospective cohort study. J Oral Maxillofac Surg. 2022, 80:1084-93. 10.1016\/j.joms.2022.01.012","journal-title":"J Oral Maxillofac Surg"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s10006-022-01061-2","article-title":"Surgical treatment of 61 consecutive patients with maxillary stage 3 medication-related osteonecrosis of the jaws using a pedicled buccal fat pad","volume":"27","author":"Andersen SW","year":"2023","unstructured":"Andersen SW, Mogensen DG, Schioedt M, Kofod T. Surgical treatment of 61 consecutive patients with maxillary stage 3 medication-related osteonecrosis of the jaws using a pedicled buccal fat pad. Oral Maxillofac Surg. 2023, 27:251-61. 10.1007\/s10006-022-01061-2","journal-title":"Oral Maxillofac Surg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3290\/j.qi.b4213007","article-title":"Revisiting best practice guidelines and patient care workflow for managing the risk of medication-related osteonecrosis of the jaw: comparative summary and case studies","volume":"54","author":"Chen J","year":"2023","unstructured":"Chen J, Wu CY, Gallagher K, Wang CW. Revisiting best practice guidelines and patient care workflow for managing the risk of medication-related osteonecrosis of the jaw: comparative summary and case studies. Quintessence Int. 2023, 54:832-43. 10.3290\/j.qi.b4213007","journal-title":"Quintessence Int"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjorl.2021.04.004","article-title":"Combined approach to treatment of advanced stages of medication-related osteonecrosis of the jaw patients","volume":"88","author":"\u015eahin O","year":"2022","unstructured":"\u015eahin O, Akan E, Tatar B, Ekmekcio\u011flu C, \u00dcnal N, Odaba\u015f\u0131 O. Combined approach to treatment of advanced stages of medication-related osteonecrosis of the jaw patients. Braz J Otorhinolaryngol. 2022, 88:613-20. 10.1016\/j.bjorl.2021.04.004","journal-title":"Braz J Otorhinolaryngol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.10.015","article-title":"Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature","volume":"51","author":"Del Fabbro M","year":"2015","unstructured":"Del Fabbro M, Gallesio G, Mozzati M. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature. Eur J Cancer. 2015, 51:62-74. 10.1016\/j.ejca.2014.10.015","journal-title":"Eur J Cancer"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-015-1528-y","article-title":"PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells","volume":"20","author":"Anitua E","year":"2016","unstructured":"Anitua E, Zalduendo M, Troya M, Orive G. PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells. Clin Oral Investig. 2016, 20:513-21. 10.1007\/s00784-015-1528-y","journal-title":"Clin Oral Investig"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14801","article-title":"Effects of daily versus weekly teriparatide for medication-related osteonecrosis of the jaw: a case-control study","author":"Kim KM","year":"2023","unstructured":"Kim KM, Kim S, Hwang H, et al.. Effects of daily versus weekly teriparatide for medication-related osteonecrosis of the jaw: a case-control study. Oral Dis. 2023, 10.1111\/odi.14801","journal-title":"Oral Dis"},{"key":"ref44","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"3","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009, 3:e123-30.","journal-title":"Open Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2021.07.010","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"74","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol (Engl Ed). 2021, 74:790-9. 10.1016\/j.rec.2021.07.010","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.17.1.59","article-title":"Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature","volume":"17","author":"Ebell MH","year":"2004","unstructured":"Ebell MH, Siwek J, Weiss BD, Woolf SH, Susman J, Ewigman B, Bowman M. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. J Am Board Fam Pract. 2004, 17:59-67. 10.3122\/jabfm.17.1.59","journal-title":"J Am Board Fam Pract"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-020-00238-8","article-title":"Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?","volume":"7","author":"Ma LL","year":"2020","unstructured":"Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?. Mil Med Res. 2020, 7:7. 10.1186\/s40779-020-00238-8","journal-title":"Mil Med Res"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.11124\/JBISRIR-D-19-00099","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn Z","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, et al.. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020, 18:2127-33. 10.11124\/JBISRIR-D-19-00099","journal-title":"JBI Evid Synth"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt GH","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008, 336:924-6. 10.1136\/bmj.39489.470347.AD","journal-title":"BMJ"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s10006-022-01042-5","article-title":"Outcome of healing after dental implant placement in patients with cancer on high-dose antiresorptive medications: a prospective feasibility study","volume":"27","author":"Andersen SW","year":"2023","unstructured":"Andersen SW, Ottesen C, Gotfredsen K, Jensen SS, Kofod T, Schiodt M. Outcome of healing after dental implant placement in patients with cancer on high-dose antiresorptive medications: a prospective feasibility study. Oral Maxillofac Surg. 2023, 27:89-100. 10.1007\/s10006-022-01042-5","journal-title":"Oral Maxillofac Surg"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/clr.14197","article-title":"Dental implant treatment in patients with cancer on high-dose antiresorptive medication: a prospective feasibility study with 2\u2009years follow-up","volume":"35","author":"Hjortholt CO","year":"2024","unstructured":"Hjortholt CO, Andersen SW, Jensen SS, Kofod T, Gotfredsen K. Dental implant treatment in patients with cancer on high-dose antiresorptive medication: a prospective feasibility study with 2\u2009years follow-up. Clin Oral Implants Res. 2024, 35:63-76. 10.1111\/clr.14197","journal-title":"Clin Oral Implants Res"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2017.01.023","article-title":"Surgical resection and vascularized bone reconstruction in advanced stage medication-related osteonecrosis of the jaw","volume":"46","author":"Caldroney S","year":"2017","unstructured":"Caldroney S, Ghazali N, Dyalram D, Lubek JE. Surgical resection and vascularized bone reconstruction in advanced stage medication-related osteonecrosis of the jaw. Int J Oral Maxillofac Surg. 2017, 46:871-6. 10.1016\/j.ijom.2017.01.023","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59030535","article-title":"MRONJ of the mandible-from decortication to a complex jaw reconstruction using a CAD\/CAM-guided bilateral scapula flap","volume":"59","author":"Kasper R","year":"2023","unstructured":"Kasper R, Scheurer M, Pietzka S, Sakkas A, Schramm A, Wilde F, Ebeling M. MRONJ of the mandible-from decortication to a complex jaw reconstruction using a CAD\/CAM-guided bilateral scapula flap. Medicina (Kaunas). 2023, 59:10.3390\/medicina59030535","journal-title":"Medicina (Kaunas)"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093300","article-title":"Zygomatic implant insertion in MRONJ: a case report with a follow-up of 3 years","volume":"12","author":"Goker F","year":"2023","unstructured":"Goker F, Grecchi E, Del Fabbro M, Longoni S, Stefanelli LV, Grecchi F. Zygomatic implant insertion in MRONJ: a case report with a follow-up of 3 years. J Clin Med. 2023, 12:10.3390\/jcm12093300","journal-title":"J Clin Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2015.08.006","article-title":"Successful long-term mandibular reconstruction and rehabilitation using non-vascularised autologous bone graft and recombinant human BMP-7 with subsequent endosseous implant in a patient with bisphosphonate-related osteonecrosis of the jaw","volume":"53","author":"Rahim I","year":"2015","unstructured":"Rahim I, Salt S, Heliotis M. Successful long-term mandibular reconstruction and rehabilitation using non-vascularised autologous bone graft and recombinant human BMP-7 with subsequent endosseous implant in a patient with bisphosphonate-related osteonecrosis of the jaw. Br J Oral Maxillofac Surg. 2015, 53:870-4. 10.1016\/j.bjoms.2015.08.006","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1563\/aaid-joi-D-20-00295","article-title":"Successful new dental implant installation in a healed site of medication-related osteonecrosis of the jaw: a case report","volume":"49","author":"Lee JY","year":"2023","unstructured":"Lee JY, Park JU, Lee SY. Successful new dental implant installation in a healed site of medication-related osteonecrosis of the jaw: a case report. J Oral Implantol. 2023, 49:117-23. 10.1563\/aaid-joi-D-20-00295","journal-title":"J Oral Implantol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1002\/cre2.620","article-title":"Medication-related osteonecrosis of the jaw and successful implant treatment in a patient on high-dose antiresorptive medication: a case report","volume":"8","author":"Ottesen C","year":"2022","unstructured":"Ottesen C, Andersen SW, Jensen SS, Kofod T, Gotfredsen K. Medication-related osteonecrosis of the jaw and successful implant treatment in a patient on high-dose antiresorptive medication: a case report. Clin Exp Dent Res. 2022, 8:1059-67. 10.1002\/cre2.620","journal-title":"Clin Exp Dent Res"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2007.06.631","article-title":"Fibula free flap with endosseous implants for reconstructing a resected mandible in bisphosphonate osteonecrosis","volume":"66","author":"Ferrari S","year":"2008","unstructured":"Ferrari S, Bianchi B, Savi A, Poli T, Multinu A, Balestreri A, Ferri A. Fibula free flap with endosseous implants for reconstructing a resected mandible in bisphosphonate osteonecrosis. J Oral Maxillofac Surg. 2008, 66:999-1003. 10.1016\/j.joms.2007.06.631","journal-title":"J Oral Maxillofac Surg"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1563\/AAID-JOI-D-13-00178","article-title":"Implant placement adjacent to successfully treated bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"41 Spec No","author":"Rugani P","year":"2015","unstructured":"Rugani P, Kirnbauer B, Acham S, Truschnegg A, Jakse N. Implant placement adjacent to successfully treated bisphosphonate-related osteonecrosis of the jaw (BRONJ). J Oral Implantol. 2015, 41 Spec No:377-81. 10.1563\/AAID-JOI-D-13-00178","journal-title":"J Oral Implantol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.5125\/jkaoms.2016.42.3.157","article-title":"Dental implant treatment after healing of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in the same region: a case report","volume":"42","author":"Kim JW","year":"2016","unstructured":"Kim JW, Baik J, Jeon JH. Dental implant treatment after healing of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in the same region: a case report. J Korean Assoc Oral Maxillofac Surg. 2016, 42:157-61. 10.5125\/jkaoms.2016.42.3.157","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.14402\/jkamprs.2014.36.2.57","article-title":"Reconstruction of defect after treatment of bisphosphonate-related osteonecrois of the jaw with staged iliac bone graft","volume":"36","author":"Ahn KJ","year":"2014","unstructured":"Ahn KJ, Kim YK, Yun PY. Reconstruction of defect after treatment of bisphosphonate-related osteonecrois of the jaw with staged iliac bone graft. Maxillofac Plast Reconstr Surg. 2014, 36:57-61. 10.14402\/jkamprs.2014.36.2.57","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.54527\/jdir.2019.38.3.82","article-title":"Rehabilitation using implants in a patient with medication related osteonecrosis of the jaw (MRONJ) and possible role of rheumatoid arthritis as a co-morbidity: report of a case","volume":"38","author":"Kim M","year":"2019","unstructured":"Kim M, Lee Y, Noh K. Rehabilitation using implants in a patient with medication related osteonecrosis of the jaw (MRONJ) and possible role of rheumatoid arthritis as a co-morbidity: report of a case. J Dent Implant Res. 2019, 38:82-8. 10.54527\/jdir.2019.38.3.82","journal-title":"J Dent Implant Res"},{"key":"ref63","doi-asserted-by":"crossref","DOI":"10.1515\/bjdm-2017-0008","article-title":"Treatment of biphosphonate-related osteonecrosis of the jaw (BRONJ) combining surgical resection and prgf-Endoret\u00ae and rehabilitation with dental implants: case report","volume":"21","author":"Anitua E","year":"2017","unstructured":"Anitua E. Treatment of biphosphonate-related osteonecrosis of the jaw (BRONJ) combining surgical resection and prgf-Endoret\u00ae and rehabilitation with dental implants: case report. Balkan Journal of Dental Medicine. 2017, 21:55-9.","journal-title":"Balkan Journal of Dental Medicine"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.11237\/jsoi.31.162","article-title":"Functional reconstruction with fibula flap and dental implants following mandibular resection of medication-related osteonecrosis of the jaw: a case report","volume":"31","author":"Teramoto Y","year":"2018","unstructured":"Teramoto Y, Uehara S, Yasunaga Y, et al.. Functional reconstruction with fibula flap and dental implants following mandibular resection of medication-related osteonecrosis of the jaw: a case report. J Japanese Soc Oral Implantol. 2018, 31:162-9. 10.11237\/jsoi.31.162","journal-title":"J Japanese Soc Oral Implantol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdsr.2021.11.005","article-title":"Medication-related osteonecrosis of the jaw: prosthodontic considerations","volume":"58","author":"Ali IE","year":"2022","unstructured":"Ali IE, Sumita Y. Medication-related osteonecrosis of the jaw: prosthodontic considerations. Jpn Dent Sci Rev. 2022, 58:9-12. 10.1016\/j.jdsr.2021.11.005","journal-title":"Jpn Dent Sci Rev"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1186\/s40729-021-00323-0","article-title":"Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review","volume":"7","author":"Kawahara M","year":"2021","unstructured":"Kawahara M, Kuroshima S, Sawase T. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. Int J Implant Dent. 2021, 7:47. 10.1186\/s40729-021-00323-0","journal-title":"Int J Implant Dent"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3390\/dj11040104","article-title":"Drugs-related osteonecrosis of the jaw in a patient affected by multiple myeloma: a case report","volume":"11","author":"Caggiano M","year":"2023","unstructured":"Caggiano M, Di Spirito F, Acerra A, Galdi M, Sisalli L. Drugs-related osteonecrosis of the jaw in a patient affected by multiple myeloma: a case report. Dent J (Basel). 2023, 11:10.3390\/dj11040104","journal-title":"Dent J (Basel)"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.5125\/jkaoms.2023.49.2.75","article-title":"Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis","volume":"49","author":"Mustakim KR","year":"2023","unstructured":"Mustakim KR, Eo MY, Lee JY, Seo MH, Kim SM. Clinical significance of drug cessation on medication-related osteonecrosis of the jaw in patients with osteoporosis. J Korean Assoc Oral Maxillofac Surg. 2023, 49:75-85. 10.5125\/jkaoms.2023.49.2.75","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline","volume":"37","author":"Yarom N","year":"2019","unstructured":"Yarom N, Shapiro CL, Peterson DE, et al.. Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline. J Clin Oncol. 2019, 37:2270-90. 10.1200\/JCO.19.01186","journal-title":"J Clin Oncol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2015.03.001","article-title":"World Workshop on Oral Medicine VI: controversies regarding dental management of medically complex patients: assessment of current recommendations","volume":"120","author":"Nape\u00f1as JJ","year":"2015","unstructured":"Nape\u00f1as JJ, Kujan O, Arduino PG, et al.. World Workshop on Oral Medicine VI: controversies regarding dental management of medically complex patients: assessment of current recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015, 120:207-26. 10.1016\/j.oooo.2015.03.001","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.11005\/jbm.2021.28.4.279","article-title":"Medication related osteonecrosis of the jaw: 2021 position statement of the Korean Society for bone and mineral research and the Korean Association of Oral and Maxillofacial Surgeons","volume":"28","author":"Kim JW","year":"2021","unstructured":"Kim JW, Kwak MK, Han JJ, et al.. Medication related osteonecrosis of the jaw: 2021 position statement of the Korean Society for bone and mineral research and the Korean Association of Oral and Maxillofacial Surgeons. J Bone Metab. 2021, 28:279-96. 10.11005\/jbm.2021.28.4.279","journal-title":"J Bone Metab"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1563\/aaid-joi-D-21-00160","article-title":"Clinical impact on dental implant survival in patients taking antiresorptive medications: a systematic review and meta-analysis","volume":"49","author":"Ting M","year":"2023","unstructured":"Ting M, Huynh BH, Woldu HG, Gamal I, Suzuki JB. Clinical impact on dental implant survival in patients taking antiresorptive medications: a systematic review and meta-analysis. J Oral Implantol. 2023, 49:599-615. 10.1563\/aaid-joi-D-21-00160","journal-title":"J Oral Implantol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3390\/ma16186078","article-title":"Bisphosphonates and dental implants: a systematic review and meta-analysis","volume":"16","author":"Sulaiman N","year":"2023","unstructured":"Sulaiman N, Fadhul F, Chrcanovic BR. Bisphosphonates and dental implants: a systematic review and meta-analysis. Materials (Basel). 2023, 16:10.3390\/ma16186078","journal-title":"Materials (Basel)"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jormas.2023.101521","article-title":"Impact of locally delivered diphosphonates on dental implants: A systematic review and meta-analysis","volume":"124","author":"Zhang J","year":"2023","unstructured":"Zhang J, Liu Z, Qiu J, Yang J. Impact of locally delivered diphosphonates on dental implants: A systematic review and meta-analysis. J Stomatol Oral Maxillofac Surg. 2023, 124:101521. 10.1016\/j.jormas.2023.101521","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.5037\/jomr.2018.9302","article-title":"Dental implant placement in patients on bisphosphonate therapy: a systematic review","volume":"9","author":"Gelazius R","year":"2018","unstructured":"Gelazius R, Poskevicius L, Sakavicius D, Grimuta V, Juodzbalys G. Dental implant placement in patients on bisphosphonate therapy: a systematic review. J Oral Maxillofac Res. 2018, 9:e2. 10.5037\/jomr.2018.9302","journal-title":"J Oral Maxillofac Res"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1038\/s41432-021-0196-9","article-title":"Is it safe to place implants in patients at risk of MRONJ?","volume":"22","author":"Owen B","year":"2021","unstructured":"Owen B, Bradley H. Is it safe to place implants in patients at risk of MRONJ?. Evid Based Dent. 2021, 22:108-9. 10.1038\/s41432-021-0196-9","journal-title":"Evid Based Dent"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2016.1154533","article-title":"Genetic and acquired factors influencing the effectiveness and toxicity of drug therapy in osteoporosis","volume":"12","author":"L\u00f3pez-Delgado L","year":"2016","unstructured":"L\u00f3pez-Delgado L, Riancho-Zarrabeitia L, Riancho JA. Genetic and acquired factors influencing the effectiveness and toxicity of drug therapy in osteoporosis. Expert Opin Drug Metab Toxicol. 2016, 12:389-98. 10.1517\/17425255.2016.1154533","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley DA","year":"2012","unstructured":"Hanley DA, Adachi JD, Bell A, Brown V. Denosumab: mechanism of action and clinical outcomes. Int J Clin Pract. 2012, 66:1139-46. 10.1111\/ijcp.12022","journal-title":"Int J Clin Pract"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3344\/kjp.2017.30.2.86","article-title":"Can denosumab be a substitute, competitor, or complement to bisphosphonates?","volume":"30","author":"Kim SY","year":"2017","unstructured":"Kim SY, Ok HG, Birkenmaier C, Kim KH. Can denosumab be a substitute, competitor, or complement to bisphosphonates?. Korean J Pain. 2017, 30:86-92. 10.3344\/kjp.2017.30.2.86","journal-title":"Korean J Pain"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1186\/s13005-021-00280-4","article-title":"A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on denosumab therapy: a hypothesis","volume":"17","author":"Campisi G","year":"2021","unstructured":"Campisi G, Mauceri R, Bertoldo F, Fusco V, Bedogni A. A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on denosumab therapy: a hypothesis. Head Face Med. 2021, 17:25. 10.1186\/s13005-021-00280-4","journal-title":"Head Face Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/251723-clinical-performance-of-implant-supported-prostheses-in-the-rehabilitation-of-patients-previously-treated-for-medication-related-osteonecrosis-of-the-jaws-mronj-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T15:16:02Z","timestamp":1717514162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/251723-clinical-performance-of-implant-supported-prostheses-in-the-rehabilitation-of-patients-previously-treated-for-medication-related-osteonecrosis-of-the-jaws-mronj-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":80,"URL":"https:\/\/doi.org\/10.7759\/cureus.61658","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,4]]}}}